Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Ofloxacin is a second-generation fluoroquinolone antibiotic used in tablet, ophthalmic and otic forms for bacterial infections. It is made through multi-step fluorine chemistry, so its cost follows natural gas, naphtha and fluorochemical prices. China and India dominate API supply, with India accounting for about 41 percent of recorded export transactions, while North America and Europe are the main formulation markets.
Pricing rose steadily through 2026. China averaged USD 41.20 per kg in the first quarter, up 2.5 percent, and USD 41.80 per kg in the second quarter, up 1.5 percent. Germany rose from USD 45.80 to USD 47.50 per kg, the United States from USD 44.20 to USD 45.80 and India from USD 35.80 to USD 37.00, lifting the global average from USD 41.75 to USD 43.03.
Ofloxacin in China was last assessed at USD 41.80 per kg in the second quarter of 2026, with the second-half range projected at USD 40.50 to USD 44.00 per kg.
Supplier news: Shaoxing Hantai Pharmaceutical, a Zhejiang API producer, reported in October output above 300 tonnes per year and customers in more than 60 countries, which supports Chinese supply in the short term. In India, Unichem's Goa plant concluded a US FDA inspection in September with five procedural observations, and Shoolin Pharma Chem was placed on FDA Import Alert in August, signalling compliance risks that may constrain Indian supply over the long term.
Elevated natural gas and naphtha feedstock costs, compounded by supply disruptions tied to global LNG issues and Middle East trade conflicts, show no clear sign of easing, which points toward continued firmness through H2 2026 across every market tracked. Steady healthcare-sector demand, supported by resilient consumer spending and prescription fulfillment, should keep supporting the market regardless of feedstock movements.
A further LNG supply disruption, or additional Middle East trade conflict escalation, could be what pushes prices above this forecast. A normalization of natural gas and naphtha feedstock costs, or expanded API production capacity, could be what eases the market back toward the lower end instead.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 41.50 - 47.00 | Feedstock costs and geopolitical disruptions support firmness |
| Germany | 46.00 - 50.00 | Elevated feedstock costs maintain the top spot |
| United States | 44.50 - 48.00 | Supply disruptions and API constraints sustain gains |
| China | 40.50 - 44.00 | Surging feedstock costs keep pricing measured |
| India | 35.50 - 39.00 | Firm export demand supports gradual gains |
Germany stayed the priciest market by a wide margin, with the price moving from about USD 45.80/KG to near USD 47.50/KG, a gain of just above 3.7%. It was continued elevated feedstock costs, together with steady pharmaceutical formulation demand, that carried the increase.
Why did the price of Ofloxacin change in Q2 2026 in Germany?
Elevated natural gas and naphtha feedstock costs have persisted, increasing manufacturing expenses across the chemical supply chain that feeds pharmaceutical production, and it is this cost pressure, combined with steady demand for broad-spectrum antibiotic formulations, that has kept German pricing at the top of the range.
The United States price moved from about USD 44.20/KG to near USD 45.80/KG, a gain of just above 3.6%. It was continued supply disruptions tied to global LNG issues and Middle East trade conflicts, together with elevated production costs, that carried the increase.
Why did the price of Ofloxacin change in Q2 2026 in United States?
Elevated natural gas and naphtha feedstock costs persisted through the quarter, increasing manufacturing expenses, and supply disruptions from global LNG issues and Middle East trade conflicts impacted availability, and it is this combination that has kept United States pricing climbing even as steady healthcare demand supports the broader market.
The Chinese price moved from about USD 41.20/KG to near USD 41.80/KG, a gain of just above 1.5%. It was continued elevated natural gas and naphtha feedstock costs, together with supply disruptions linked to Middle East trade conflicts, that carried the increase.
Why did the price of Ofloxacin change in Q2 2026 in China?
Elevated natural gas and naphtha feedstock costs persisted throughout the quarter, increasing manufacturing expenses, and supply disruptions from global LNG issues and Middle East trade conflicts impacted availability, and it is this combination that has kept Chinese pricing climbing even as it remains the most affordable of the four markets tracked.
The Indian price moved from about USD 35.80/KG to near USD 37.00/KG, a gain of just above 3.4%. It was continued firm export demand, together with firming feedstock costs, that carried the increase.
Why did the price of Ofloxacin change in Q2 2026 in India?
India's substantial export production base has kept demand consistently firm, and it is this steady offtake, combined with elevated feedstock costs affecting producers globally, that has kept Indian pricing on a gradual upward path even as it remains the most affordable of the four markets tracked.
The price reached close to USD 45.80/KG in Q1 2026, a rise of just above 4.1% from Q4 2025. It was elevated feedstock costs, together with steady demand from pharmaceutical formulators, that pushed the market higher.
Why did the price of Ofloxacin change in Q1 2026 in Germany?
Feedstock costs firmed entering the year as energy and chemical input prices rose broadly, and it was this cost pressure, meeting steady demand from pharmaceutical formulators treating a wide range of bacterial infections, that drove the German increase.
The price reached close to USD 44.20/KG in Q1 2026, a rise of just above 4.0% from Q4 2025. It was elevated production costs, together with API availability constraints restricting generic production, that pushed the market higher.
Why did the price of Ofloxacin change in Q1 2026 in United States?
Producer prices rose meaningfully in March, directly increasing API synthesis and formulation costs, and industrial production grew, limiting excess supply, and pharmacy-level inventories of sterile ophthalmic solutions tightened significantly due to regional stockouts, and it was this combination of cost pressure and supply tightness that drove the United States increase.
The price reached close to USD 41.20/KG in Q1 2026, a rise of just above 2.5% from Q4 2025. It was surging upstream feedstock costs, together with rising factory-gate prices, that pushed the market higher.
Why did the price of Ofloxacin change in Q1 2026 in China?
Surging upstream feedstock costs drove the Chinese increase this quarter, and factory-gate prices rose as reflected in a rising producer price index, and it was this cost pressure, meeting steady domestic and export demand, that drove the increase.
The price reached close to USD 35.80/KG in Q1 2026, a rise of just above 3.8% from Q4 2025. It was firming feedstock costs, together with steady export demand, that pushed the market higher.
Why did the price of Ofloxacin change in Q1 2026 in India?
Feedstock costs firmed entering the year, and it was this cost pressure, meeting steady export demand for this broad-spectrum antibiotic treating skin, eye, and other bacterial infections, that drove the Indian increase.
This market climbed steadily across every quarter tracked here. Close to USD 37.25/KG in Q1 2025 rose to about USD 38.30/KG, near USD 39.50/KG, and close to USD 40.30/KG by Q4, before continuing to about USD 41.75/KG in Q1 2026 and near USD 43.03/KG in Q2. That is a rise of roughly 15.5% across the window, tracking feedstock costs and steady healthcare demand closely.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 43.03 | +3.1% | ↑ Rising |
| Q1 2026 | 41.75 | +3.6% | ↑ Rising |
| Q4 2025 | 40.30 | +2.0% | ↑ Rising |
| Q3 2025 | 39.50 | +3.1% | ↑ Rising |
| Q2 2025 | 38.30 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
It was steady demand for prescription fulfillment, supported by resilient healthcare spending, meeting API availability constraints and elevated feedstock costs, that drove the consistent 2025 climb. The global average opened near USD 37.25/KG in Q1 and climbed to close to USD 40.30/KG by Q4, a rise of just above 8.2% for the year, with every quarter posting a gain.
The German price climbed from about USD 40.50/KG in Q1 2025 to near USD 44.00/KG by Q4, a rise of just above 8.6% for the year, holding the highest absolute cost among the four markets tracked throughout. It was steady demand from pharmaceutical formulation, meeting elevated feedstock and compliance costs, that drove the sustained climb through 2025.
The United States price climbed from about USD 39.00/KG in Q1 2025 to near USD 42.50/KG by Q4, a rise of just above 9.0% for the year. It was steady demand for prescription fulfillment, supported by resilient consumer confidence and healthcare spending, meeting API availability constraints that restricted overall generic production, that drove the sustained climb through 2025.
The Chinese price climbed from about USD 37.50/KG in Q1 2025 to near USD 40.20/KG by Q4, a rise of just above 7.2% for the year, the smallest absolute cost among the four markets tracked throughout. It was surging upstream feedstock costs, meeting China's substantial production base serving both domestic and export markets, that drove the sustained climb through 2025.
The Indian price climbed from about USD 32.00/KG in Q1 2025 to near USD 34.50/KG by Q4, a rise of just above 7.8% for the year. It was steady export demand, meeting India's substantial production base serving both pharmaceutical and veterinary applications, that drove the gradual climb through 2025.
Expert Market Research: Your Source for Real-Time Ofloxacin Price Intelligence
The Ofloxacin market depends on both energy-intensive feedstock economics and international supply chain conditions, so Expert Market Research tracks natural gas and naphtha feedstock costs closely alongside geopolitical developments affecting global LNG and trade flows and healthcare-sector demand cycles across the four markets covered here. This is combined with trade flow data to build the forecasts. Should the Ofloxacin pricing data or procurement strategy support be needed, the team is ready to help.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It serves as a broad-spectrum antibiotic treating bacterial infections in different parts of the body, including skin infections, pneumonia, and eye infections such as conjunctivitis and corneal ulcers. Veterinary applications also account for meaningful demand.
As of Q2 2026, Germany averages near USD 47.50/KG, the United States about USD 45.80/KG, China close to USD 41.80/KG, and India roughly USD 37.00/KG. Germany remains the priciest of the four markets tracked.
The price kept climbing, from close to USD 40.30/KG in Q4 2025 up to about USD 41.75/KG in Q1 2026, then near USD 43.03/KG in Q2, a gain of just above 3.1%. Feedstock costs and geopolitical supply disruptions drove both quarters.
Supply disruptions from global LNG issues and Middle East trade conflicts have impacted availability broadly, since natural gas and naphtha feedstock costs feed directly into the energy-intensive synthesis and formulation processes used to manufacture this API.
The global average is likely to run in the USD 41.50 to 47.00/KG range, with feedstock costs and geopolitical disruptions continuing to support firmness through the back half of the year.
Germany carries the highest cost on elevated feedstock costs. The United States sits close behind on supply disruptions and API constraints, China in the middle, and India prices lowest thanks to its large export production base.
This data is refreshed on a monthly basis, with real-time figures available directly from the team.
Natural gas and naphtha feedstock costs sit at the core, given the energy-intensive nature of API synthesis. Geopolitical disruptions affecting global LNG and trade flows, and healthcare-sector demand supported by prescription and out-of-pocket spending, add further influence.
China and India dominate global production of pharmaceutical raw materials and APIs including this one, with the United States and Germany representing significant consuming markets that depend partly on imports for their formulation needs.
Natural gas and naphtha feedstock cost trends are usually the earliest signal worth tracking, since they tend to move before the finished API price does. Watching geopolitical developments affecting global LNG and trade flows also helps anticipate supply-driven price swings before they reach quoted prices.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.